Abstract:CASK is a scaffold protein that functions in trafficking and targeting of synaptic proteins in the central nervous system. Emerging literature suggests that CASK localizes inside nucleus and might regulate transcription by interacting with TBR1, a transcription factor essential for brain development. However, these regulatory mechanisms are not well established. We hypothesize that CASK is involved in neuronal activity‐regulated transcription. To test our hypothesis, we used primary cultures of mouse cortical neurons stimulated with KCL depolarization buffer, which is known to activate a robust CREB‐dependent gene expression program and to induce the activation of distal enhancer elements. To measure gene expression genome‐wide, we performed RNAseq in unstimulated or KCL‐treated neurons after knock‐down of CASK expression using specific shRNA. Our results show that CASK knock‐down strongly reduces the number of genes that are regulated by depolarization. These results indicate that CASK is required for gene expression regulation in neuronal cells. To gain further insights in the mechanisms by which CASK regulate transcription, we used RNA in situ hybridization (RNAscope) to test the hypothesis that CASK is not only required for the transcription of coding genes, but also of non‐coding RNAs, termed ‘enhancer RNAs (eRNAs), in proximity of KCL‐regulated genes. We showed that RNAscope is a valid method to measure eRNAs induction after KCl treatment. Ongoing experiments in the lab are assessing the effect of CASK knock‐down on eRNA transcription. Interestingly, we observed by immunoprecipitation that nuclear CASK dimerizes, and that the stability of this homodimer is dependent on the presence of RNA. Finally, we used biochemical fractionation to study CASK localization in the nucleus in both mouse neuronal cultures and brain tissues. These results shed light on how CASK functions in neurons. This study is relevant to human disease because mutations in CASK gene are linked to microcephaly and X‐linked intellectual disability. This project has been supported by CABRI Undergraduate Research Fellowship

CRISPR associated enzymes are mislocalized to the cytoplasm in iPSC-derived neurons resulting in KRAB-specific degradation

A Cre-Dependent CRISPR/dCas9 System for Gene Expression Regulation in Neurons

An Improved CRISPR/dCas9 Interference Tool for Neuronal Gene Suppression

Electrophysiological Study of Synaptotagmin I Deletion Using CRISPR/Cas9

CRISPR/Cas9-Mediated Gene Knock-Down in Post-Mitotic Neurons

CRISPR interference-based specific and efficient gene inactivation in the brain

CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons

Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice

Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model

Temporal Restriction of Cas9 Expression Improves CRISPR-Mediated Deletion Efficacy and Fidelity

The Bacterial Enzyme Cas13 Interferes with Neurite Outgrowth from Cultured Cortical Neurons

Optical Genome Mapping Reveals Genomic Alterations upon Gene Editing in hiPSCs: Implications for Neural Tissue Differentiation and Brain Organoid Research

CRISPRi with barcoded expression reporters dissects regulatory networks in human cells

A Neuron-Optimized CRISPR/dCas9 Activation System for Robust and Specific Gene Regulation

Targeted gene silencing in the nervous system with CRISPR-Cas13

Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium

CRISPR-mediated Loss of Function Analysis in Cerebellar Granule Cells Using in Utero Electroporation-based Gene Transfer

Supramolecular Nanosubstrate‐Mediated Delivery for CRISPR/Cas9 Gene Disruption and Deletion

‐The Function of CASK in Transcriptional Regulation in Neurons

CRISPRi: a way to integrate iPSC-derived neuronal models

Efficient in vivo neuronal genome editing in the mouse brain using nanocapsules containing CRISPR-Cas9 ribonucleoproteins